Mesa Laboratories Inc (MLAB)

Net profit margin

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Net income (ttm)	US$ in thousands	-1,974	-249,443	-245,651	-250,309	-254,246	948	-717	1,819	930	-1,465	-3,976	-1,562	1,871	7,575	5,093	4,052	3,082	-2,518	-2,606	-2,223
Revenue (ttm)	US$ in thousands	240,978	237,747	228,380	223,712	216,187	212,874	213,688	219,272	219,080	222,368	222,777	199,868	184,335	163,420	142,896	138,916	133,937	130,181	127,664	121,340
Net profit margin		-0.82%	-104.92%	-107.56%	-111.89%	-117.60%	0.45%	-0.34%	0.83%	0.42%	-0.66%	-1.78%	-0.78%	1.01%	4.64%	3.56%	2.92%	2.30%	-1.93%	-2.04%	-1.83%

March 31, 2025 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-1,974K ÷ $240,978K
= -0.82%

Mesa Laboratories Inc's net profit margin has experienced significant fluctuations over the past few years, as evidenced by the provided data. The company's net profit margin was negative in several quarters, indicating that its expenses exceeded its revenues during those periods.

From March 31, 2021, to December 31, 2023, Mesa Laboratories Inc was able to achieve positive net profit margins, with the highest margin of 4.64% recorded in December 31, 2021. However, in the subsequent quarters, the company's profitability deteriorated significantly, with negative net profit margins reaching as low as -117.60% in March 31, 2024.

It is important to note that a negative net profit margin could be a cause for concern as it implies that the company is either operating at a loss or its profit margins are extremely low. Mesa Laboratories Inc may need to reassess its cost structures, pricing strategies, and revenue streams to improve its profitability and sustain its financial health in the long term.